CovidChloroV1, Main, Corpus, bibRecord, 000F42

Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al.

Identifieur interne : 000F42 ( Main/Corpus ); précédent : 000F41; suivant : 000F43

Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al.

Auteurs : Ali Duarte-García ; Elizabeth R. Graef ; Jean W. Liew ; Maximilian F. Konig ; Alfred Hyoungju Kim ; Jeffrey A. Sparks

Source :

Annals of the rheumatic diseases [ 1468-2060 ] ; 2020.

RBID : pubmed:32769149
DOI: 10.1136/annrheumdis-2020-218680
PubMed: 32769149
PubMed Central: PMC8075104

Links to Exploration step

pubmed:32769149

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Response to: 'Correspondence on '<i>Festina lente</i>
: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef <i>et al</i>
' by Lo <i>et al</i>
.</title>
<author><name sortKey="Duarte Garcia, Ali" sort="Duarte Garcia, Ali" uniqKey="Duarte Garcia A" first="Ali" last="Duarte-García">Ali Duarte-García</name>
<affiliation><nlm:affiliation>Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name>
<affiliation><nlm:affiliation>COVID-19 Global Rheumatology Alliance, Boston, Massachusetts, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name>
<affiliation><nlm:affiliation>Divison of Rheumatology, Boston University, Boston, Massachusetts, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name>
<affiliation><nlm:affiliation>Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kim, Alfred Hyoungju" sort="Kim, Alfred Hyoungju" uniqKey="Kim A" first="Alfred Hyoungju" last="Kim">Alfred Hyoungju Kim</name>
<affiliation><nlm:affiliation>Medicine/Rheumatology, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sparks, Jeffrey A" sort="Sparks, Jeffrey A" uniqKey="Sparks J" first="Jeffrey A" last="Sparks">Jeffrey A. Sparks</name>
<affiliation><nlm:affiliation>Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32769149</idno>
<idno type="pmid">32769149</idno>
<idno type="doi">10.1136/annrheumdis-2020-218680</idno>
<idno type="pmc">PMC8075104</idno>
<idno type="wicri:Area/Main/Corpus">000F42</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000F42</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Response to: 'Correspondence on '<i>Festina lente</i>
: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef <i>et al</i>
' by Lo <i>et al</i>
.</title>
<author><name sortKey="Duarte Garcia, Ali" sort="Duarte Garcia, Ali" uniqKey="Duarte Garcia A" first="Ali" last="Duarte-García">Ali Duarte-García</name>
<affiliation><nlm:affiliation>Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name>
<affiliation><nlm:affiliation>COVID-19 Global Rheumatology Alliance, Boston, Massachusetts, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name>
<affiliation><nlm:affiliation>Divison of Rheumatology, Boston University, Boston, Massachusetts, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name>
<affiliation><nlm:affiliation>Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kim, Alfred Hyoungju" sort="Kim, Alfred Hyoungju" uniqKey="Kim A" first="Alfred Hyoungju" last="Kim">Alfred Hyoungju Kim</name>
<affiliation><nlm:affiliation>Medicine/Rheumatology, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sparks, Jeffrey A" sort="Sparks, Jeffrey A" uniqKey="Sparks J" first="Jeffrey A" last="Sparks">Jeffrey A. Sparks</name>
<affiliation><nlm:affiliation>Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32769149</PMID>
<DateRevised><Year>2021</Year>
<Month>04</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Aug</Month>
<Day>07</Day>
</PubDate>
</JournalIssue>
<Title>Annals of the rheumatic diseases</Title>
<ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Response to: 'Correspondence on '<i>Festina lente</i>
: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef <i>et al</i>
' by Lo <i>et al</i>
.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">annrheumdis-2020-218680</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-218680</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duarte-García</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Graef</LastName>
<ForeName>Elizabeth R</ForeName>
<Initials>ER</Initials>
<AffiliationInfo><Affiliation>COVID-19 Global Rheumatology Alliance, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liew</LastName>
<ForeName>Jean W</ForeName>
<Initials>JW</Initials>
<AffiliationInfo><Affiliation>Divison of Rheumatology, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Konig</LastName>
<ForeName>Maximilian F</ForeName>
<Initials>MF</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-5045-5255</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName>
<ForeName>Alfred Hyoungju</ForeName>
<Initials>AH</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-4074-0516</Identifier>
<AffiliationInfo><Affiliation>Medicine/Rheumatology, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Sparks</LastName>
<ForeName>Jeffrey A</ForeName>
<Initials>JA</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-5556-4618</Identifier>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>T32 AR048522</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ann Rheum Dis</MedlineTA>
<NlmUniqueID>0372355</NlmUniqueID>
<ISSNLinking>0003-4967</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arthritis</Keyword>
<Keyword MajorTopicYN="N">cardiovascular diseases</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">rheumatoid</Keyword>
</KeywordList>
<CoiStatement>Competing interests: JWL reports grant funding from Pfizer, unrelated to this manuscript. MFK was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) under award no. T32AR048522 and received personal fees from Bristol-Myers Squibb and Celltrion, unrelated to this manuscript. AHK reports grants from Rheumatology Research Foundation, support from NIH/NIAMS, and personal fees from Exagen Diagnostics, and GlaxoSmithKline. JAS reports grants from NIH/NIAID/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute, and the R Bruce and Joan M Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>07</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>07</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pmc-release"><Year>2022</Year>
<Month>02</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>8</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>8</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>8</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32769149</ArticleId>
<ArticleId IdType="pii">annrheumdis-2020-218680</ArticleId>
<ArticleId IdType="doi">10.1136/annrheumdis-2020-218680</ArticleId>
<ArticleId IdType="pmc">PMC8075104</ArticleId>
<ArticleId IdType="mid">NIHMS1689930</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Ann Rheum Dis. 2020 Jun;79(6):734-736</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32295786</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Saf. 2018 Oct;41(10):919-931</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29858838</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Heart Rhythm. 2020 Sep;17(9):1425-1433</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32407884</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ACR Open Rheumatol. 2020 Aug;2(8):491-495</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32725866</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 May 18;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32424027</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Oct 20;173(8):623-631</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32673060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Heart Rhythm. 2020 Sep;17(9):1472-1479</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32438018</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Heart Rhythm. 2020 Sep;17(9):1452-1455</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32380291</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Jun 23;323(24):2493-2502</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32392282</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Aug 7;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32769154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Nov 19;383(21):2041-2052</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32706953</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Cardiol. 2020 Sep 1;5(9):1036-1041</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32936252</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Heart Assoc. 2020 Jun 16;9(12):e017144</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32463348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Heart Rhythm. 2020 Nov;17(11):1930-1935</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32610165</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Jun 2;172(11):754-755</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32232419</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F42 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000F42 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32769149
   |texte=   Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32769149" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al.

Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al.

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki